Effects of Microrna-135A on the Epithelial–mesenchymal Transition, Migration and Invasion of Bladder Cancer Cells by Targeting GSK3β Through the Wnt/β-catenin Signaling Pathway
Xia-Wa Mao,Jia-Quan Xiao,Zhong-Yi Li,Yi-Chun Zheng,Nan Zhang
DOI: https://doi.org/10.1038/emm.2017.239
2018-01-01
Experimental & Molecular Medicine
Abstract:This study investigated the effects of microRNA-135a (miR-135a) targeting of glycogen synthase kinase 3β (GSK3β) on the epithelial–mesenchymal transition (EMT), migration and invasion of bladder cancer (BC) cells by mediating the Wnt/β-catenin signaling pathway. BC and adjacent normal tissues were collected from 165 BC patients. Western blotting and quantitative real-time PCR were used to detect the expression of GSK3β, β-catenin, cyclinD1, E-cadherin, vimentin and miR-135a in BC tissues and cells. Cells were assigned to blank, negative control (NC), miR-135a mimics, miR-135a inhibitors, small interfering RNA (siRNA)-GSK3β or miR-135a inhibitors+siRNA-GSK3β groups. miR-135a, β-catenin, cyclinD1 and vimentin expression increased, while GSK3β and E-cadherin expression decreased in BC tissues compared with adjacent normal tissues. Compared with the blank and NC groups, the expression of miR-135a, β-catenin, cyclinD1 and vimentin was higher, and cell proliferation, migration, invasion and tumor growth were increased in the miR-135a mimics and siRNA-GSK3β groups. These groups showed an opposite trend in GSK3β and E-cadherin expression and cell apoptosis. The miR-135a inhibitors group was inversely correlated with the blank and NC groups. It was concluded that miR-135a accelerates the EMT, invasion and migration of BC cells by activating the Wnt/β-catenin signaling pathway through the downregulation of GSK3β expression. The small regulatory RNA molecule microRNA-135a contributes to bladder cancer by stimulating cell proliferation and migration. Dr Nan Zhang and colleagues at Zhejiang University Medical College in Hangzhou, China, examined both bladder cancer and adjacent normal tissues in 156 patients. The levels of microRNA-135a and of the signaling protein β-catenin were higher in the cancerous tissue. In contrast, the levels of the tumor suppressor glycogen synthase kinase-3 beta (GSK-3β) were lower, suggesting that micro-RNA135a triggers signaling through the Wnt/β-catenin pathway. This evolutionarily conserved pathway is crucial for orchestrating development and when deregulated can lead to diseases including cancer and osteoporosis. Increased expression of micro-RNA135a stimulated cell proliferation and motility in human bladder cells and tumor growth in mice through this signaling pathway. These findings could lead to new treatment strategies for bladder cancer patients.